Infanrix (DTaP Pediatric)

Approved for INFANRIX is indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks through 6 years (prior to the seventh birthday).. Diphtheria Diphtheria is an acute toxin-mediated infectious disease caused by toxigenic strains of C. diphtheriae . Protection against disease is due to the development of neutralizing…

Loading full data from Know Your Drugs Institute…